GlassScriptPhysician profile
Dagon J Percer
NPI 1265467922
$3,832.79
in general payments reported to CMS, 2019-2025
21 companies · $903 in 2025
The $903 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.99 · 2020: $86.02 · 2021: $542 · 2022: $833 · 2023: $675 · 2024: $745 · 2025: $903.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,322.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,636.32 | 2021-2025 | Grafix Pl, Stravix Pl, Stravix |
| Organogenesis INC. | $460.71 | 2021-2024 | Puraply |
| Stryker Corporation | $279.11 | 2021-2023 | Augment Injectable |
| Biocomposites INC | $71.43 | 2025 | Stimulan |
| Musculoskeletal Transplant Foundation INC. | $71.33 | 2020 | |
| Horizon Therapeutics Plc | $46.13 | 2021-2023 | Krystexxa |
| Amgen INC. | $38.42 | 2024-2025 | Krystexxa |
| Djo, LLC | $25.09 | 2025 | Cmf |
| Medtronic, INC. | $23.83 | 2025 | Intellis Adaptivestim |
| Integra Lifesciences Corporation | $20.03 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Abbott Laboratories | $18.42 | 2025 | Eterna |
| Grt US Holding, INC. | $16.83 | 2022 | |
| Sanara Medtech INC. | $16.48 | 2024 | Celleraterx |
| Fidia Pharma USA INC. | $14.99 | 2022 | |
| Depuy Synthes Sales INC. | $14.86 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $14.69 | 2020 | |
| Kci USA, INC. | $14.19 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.13 | 2022 | |
| Novo Nordisk INC | $12.61 | 2019 | |
| Medartis INC. | $11.89 | 2019 | |
| Assertio Therapeutics, INC. | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dagon Percer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.